Overall Fundamental outlook

Business Operations:

Sector: Healthcare
Industry: Diagnostics & Research

Dr. Lal PathLabs Limited operates laboratories for carrying out pathological investigations in India and internationally. The company provides pathological investigations of various branches of bio-chemistry, hematology, histopathology, microbiology, electrophoresis, immuno-chemistry, immunology, virology, cytology, and other pathological and radiological investigations. It also offers training programs. The company was founded in 1949 and is based in Gurugram, India.

Revenue projections:

Revenue projections for LALPATHLAB
Revenue projections for LALPATHLAB

Dr. Lal PathLabs Limited is projected to see a decline in revenue compared to last year, which could lead to investor caution. A drop in earnings is often viewed as a negative signal for profitability, making it more difficult for the company to maintain investor confidence in its financial health.

Financial Ratios:

currentRatio 3.47600
forwardPE 38.93565
debtToEquity 7.83100
earningsGrowth -0.15400
revenueGrowth 0.16600
grossMargins 0.62434
operatingMargins 0.20236
trailingEps 31.65000
forwardEps 41.19618

LALPATHLAB's current ratio is 3.476, showing the company's capacity to service its short-term debt through its cash reserves and current assets. This is a positive indicator of liquidity, suggesting LALPATHLAB has no trouble covering its short-term financial obligations.
LALPATHLAB's low earnings and revenue growth suggest that the company may see declining profits. This indicates potential financial challenges ahead, and could lead to a more cautious outlook from investors.
With positive gross and operating margins, Dr. Lal PathLabs Limited demonstrates its profitability and efficiency. These metrics show that the company is managing costs well while generating strong revenue, highlighting robust financial health.
LALPATHLAB's forward EPS being higher than its trailing EPS signals anticipated growth in profitability for the current financial year. This suggests that LALPATHLAB is on track to improve its earnings, outpacing the previous year's performance and reflecting positive market expectations.

Price projections:

Price projections for LALPATHLAB
Price projections for LALPATHLAB

The price of LALPATHLAB has regularly been close to the lower end of projections, suggesting that it might be struggling to meet market expectations. This trend raises questions about the company's future performance.

Insider Transactions:

Insider Transactions for LALPATHLAB
Insider Transactions for LALPATHLAB


42 sales transactions of LALPATHLAB were conducted, with market price at 2768.952378045945.There were 1 buy transactions of LALPATHLAB, with market price at 3308.5.Insider transactions show no notable pattern, making it difficult to discern whether these actions signal positive or negative developments within the company.

Recommendation changes over time:

Recommendations trend for LALPATHLAB
Recommendations trend for LALPATHLAB


Analysts have shown a buy bias for Dr. Lal PathLabs Limited, marking it as a favorable investment option. This could inspire investors to see Dr. Lal PathLabs Limited as a strong place to park their money, given the positive outlook and growth potential associated with the stock in recent evaluations.